Ask AI
ProCE Banner Activity

Complementing PARP Inhibition in Metastatic CRPC: PARP Inhibitors as Single Agents

Slideset

Download this slideset with the most up-to-date data on the use of PARP inhibitors as single-agent therapy in patients with mCRPC, including recent trial updates and information on current clinical guidelines.

Released: May 30, 2025

Expiration: November 29, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Johnson & Johnson and Pfizer Inc.

Johnson & Johnson

Pfizer, Inc.